Humana (HUM) Jumps 15% as 95% of Medicare Members Land Four-Star Plans for 2027

TLDR

Table of Contents

95% of Humana’s Medicare Advantage enrollees now participate in plans rated four stars or higher for the 2027 coverage year.
Shares of Humana rise roughly 15% during premarket hours after the company discloses improved Star Ratings from federal regulators.
Eighteen contracts receive top-tier ratings: six earn 4.5 stars and twelve achieve four-star status for 2027.
The insurer documents 534,000 additional preventive care appointments and enhanced screening completion rates for critical health conditions.
Open enrollment for Medicare coverage launches October 15, with selected plans becoming active January 1, 2027.

Humana Inc. (NYSE: HUM) announced enhanced Medicare Advantage Star Ratings for the 2027 coverage period on Friday. The disclosure prompted significant interest in Humana stock as market participants assessed the quality score improvements.

Humana Inc., HUM

The health insurer disclosed that 95% of its Medicare Advantage enrollees hold coverage through plans carrying ratings of four stars or above. Plans rated 4.5 stars serve 42% of Humana’s membership base.

Share Price Responds to Enhanced Quality Metrics

Humana stock advanced approximately 15% during Friday’s premarket trading, according to Reuters. Federal quality ratings determine which health plans receive performance-based incentive payments from the government.

Membership in four-star-or-better plans stood at 20% for the 2026 period. Analysts at JPMorgan had projected figures between 60% and 70%. Previous years saw lower ratings that restricted Humana’s access to quality-linked government reimbursements.

In unrelated market activity, European healthcare stocks moved higher on October 6 following clinical trial updates. That development involved separate entities with no relation to Humana’s quality ratings.

Contract Portfolio Achieves Stronger Federal Grades

Humana tallied six Medicare Advantage contracts earning 4.5-star designations and twelve receiving four-star grades for the 2027 period. The combined figure represents an increase of 11 contracts compared to the previous year.

The company’s prescription drug plan also secured a 4.5-star rating. Federal Medicare administrators evaluate health plans each year based on care quality metrics, customer service performance, and member satisfaction.

In separate industry news, HeartBeam received FDA breakthrough device status for home-based heart attack detection technology. The regulatory designation represents a development pathway rather than final approval and bears no connection to insurance quality ratings.

Screening and Prevention Programs Deliver Measurable Results

Humana documented 663,000 additional completed care opportunities compared to the prior year. The insurer’s outreach initiatives brought 534,000 members to annual preventive care appointments.

Targeted outreach campaigns led to 28,000 individuals completing overdue mammography screenings. Those examinations detected 600 breast cancer cases that had previously gone unidentified, according to Humana.

Another 93,000 enrollees completed delayed colorectal cancer screenings, which identified 100 instances of cancer or precancerous conditions. Among members living with diabetes, 73,000 underwent overdue eye examinations, revealing 17,000 previously undiagnosed cases of diabetes-related eye disease.

Annual Selection Period Begins for 2027 Coverage

The annual enrollment window for Medicare Advantage and prescription drug plans operates from October 15 through December 7, 2026. Eligible individuals can review quality ratings while evaluating coverage options. The Centers for Medicare & Medicaid Services noted that 71% of Medicare Advantage drug plan participants would have access to contracts rated four stars or higher.

In unrelated corporate news, Haemonetics stock gained on October 8 after announcing equipment deployment plans across U.S. plasma collection centers. The company manufactures medical devices rather than offering Medicare plans.

Coverage choices made during the annual enrollment period take effect January 1, 2027. Humana’s updated quality scores will display alongside other plan information for beneficiaries evaluating available options.